Companies included in HELX
This is HELX's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–61 of 61.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| GH | Guardant Health Inc | 15,718 | NS | 6.769554% |
| NTRA | NATERA INC | 7,131 | NS | 6.649524% |
| KRYS | Krystal Biotech Inc | 4,418 | NS | 5.321273% |
| UTHR | United Therapeutics Corporation | 1,680 | NS | 4.644951% |
| INSM | Insmed Inc | 5,932 | NS | 4.522763% |
| BBIO | Bridgebio Pharma Inc | 12,192 | NS | 4.221451% |
| LGND | Ligand Pharmaceuticals Incorporated | 3,794 | NS | 3.531819% |
| AZN | AstraZeneca PLC | 3,695 | NS | 3.397795% |
| ADPT | Adaptive Biotechnologies Corp | 48,245 | NS | 3.122293% |
| VRTX | Vertex Pharmaceuticals Incorporated | 1,435 | NS | 2.987749% |
| 207940 | Samsung Biologics Co Ltd | 652 | NS | 2.985161% |
| MEDP | Medpace Holdings Inc. | 1,327 | NS | 2.97109% |
| REGN | Regeneron Pharmaceuticals, Inc. | 748 | NS | 2.694701% |
| CTVA | Corteva Inc | 6,904 | NS | 2.694697% |
| ALNY | Alnylam Pharmaceuticals Inc. | 1,687 | NS | 2.602581% |
| LLY | Eli Lilly & Co. | 593 | NS | 2.543114% |
| IONS | Ionis Pharmaceuticals, Inc. | 5,957 | NS | 2.085651% |
| TEM | Tempus AI Inc. | 8,726 | NS | 1.83983% |
| BNTX | BioNTech SE | 4,340 | NS | 1.798563% |
| NBIX | Neurocrine Biosciences Inc | 2,693 | NS | 1.654192% |
| STOK | Stoke Therapeutics Inc | 10,539 | NS | 1.599984% |
| TWST | Twist Bioscience Corporation | 7,184 | NS | 1.591749% |
| ARGX | Argenx SE | 459 | NS | 1.53082% |
| PTCT | PTC Therapeutics, Inc. | 4,652 | NS | 1.47778% |
| TVTX | Travere Therapeutics Inc | 10,129 | NS | 1.40314% |
| CRL | Charles River Laboratories International, Inc. | 1,445 | NS | 1.162221% |
| CRSP | CRISPR Therapeutics AG | 4,671 | NS | 1.036036% |
| RGEN | Repligen Corporation | 1,866 | NS | 1.025091% |
| VCYT | Veracyte Inc | 6,788 | NS | 1.019446% |
| PRAX | Praxis Precision Medicines Inc | 667 | NS | 1.002005% |
| GRAL | GRAIL Inc | 4,138 | NS | 0.997114% |
| SOAGY | Sartorius AG | 841 | NS | 0.957385% |
| DHR | Danaher Corporation | 1,050 | NS | 0.928238% |
| TMO | Thermo Fisher Scientific Inc | 391 | NS | 0.896104% |
| IQV | IQVIA Holdings Inc. | 1,005 | NS | 0.799142% |
| BEAM | BEAM THERAPEUTICS INC | 7,036 | NS | 0.781775% |
| JAZZ | Jazz Pharmaceuticals PLC | 841 | NS | 0.741318% |
| CPRX | Catalyst Pharmaceuticals Inc. | 6,375 | NS | 0.735974% |
| CDNS | Cadence Design Systems, Inc. | 545 | NS | 0.706106% |
| A | Agilent Technologies Inc. | 1,136 | NS | 0.603725% |
| CDNA | Caredx Inc | 7,429 | NS | 0.601329% |
| QGEN | QIAGEN NV | 3,175 | NS | 0.592747% |
| ANAB | AnaptysBio Inc. | 2,041 | NS | 0.527782% |
| 0126Z0 | SAMSUNG EPIS HOLDINGS CO LTD | 350 | NS | 0.526341% |
| TARS | Tarsus Pharmaceuticals Inc | 1,487 | NS | 0.486374% |
| RARE | Ultragenyx Pharmaceuticals Inc | 4,765 | NS | 0.465456% |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 4,107 | NS | 0.451161% |
| AXSM | Axsome Therapeutics Inc. | 566 | NS | 0.446053% |
| WGS | GeneDx Holdings Corp | 1,409 | NS | 0.421903% |
| RYTM | Rhythm Pharmaceuticals Inc | 974 | NS | 0.394966% |
| HNGE | HINGE HEALTH INC | 2,182 | NS | 0.392305% |
| BMY | Bristol-Myers Squibb Company | 1,111 | NS | 0.314179% |
| BIO | Bio-Rad Laboratories, Inc. | 226 | NS | 0.293735% |
| ONC | BEONE MEDICINES LTD | 209 | NS | 0.289395% |
| TMDX | TransMedics Group Inc. | 482 | NS | 0.223413% |
| NGNE | Neurogene Inc. | 1,840 | NS | 0.172958% |
| WVE | Wave Life Sciences Ltd. | 4,470 | NS | 0.151104% |
| RXRX | Recursion Pharmaceuticals Inc | 10,393 | NS | 0.148769% |
| CAI | Caris Life Sciences Inc. | 557 | NS | 0.046436% |
| 2200963D | OMNIAB INC | 240 | NS | 0% |
| 2200964D | OMNIAB INC | 240 | NS | 0% |
SEC N-PORT snapshot as of .